Evidence map›Paper›PMID 30077736›Full record

ArticleJournal of controlled release : official journal of the Controlled Release Society2018

Degradable poly(ethylene glycol) (PEG)-based hydrogels for spatiotemporal control of siRNA/nanoparticle delivery.

Yuchen Wang, Sue Zhang, Danielle S W Benoit

Abstract read
In one paragraph

Article in Journal of controlled release : official journal of the Controlled Release Society, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Yuchen WangDepartment of Biomedical Engineering, 308 Robert B. Goergen Hall, University of Rochester, Rochester, NY 14627, USA; Center for Musculoskeletal Research, 601 Elmwood Ave, University of Rochester Medical Center, Rochester, NY 14642, USA. Electronic address: yuchen.wang@rochester.edu.
Sue ZhangDepartment of Biomedical Engineering, 308 Robert B. Goergen Hall, University of Rochester, Rochester, NY 14627, USA. Electronic address: Sue.zhang@rochester.edu.
Danielle S W BenoitDepartment of Biomedical Engineering, 308 Robert B. Goergen Hall, University of Rochester, Rochester, NY 14627, USA; Center for Musculoskeletal Research, 601 Elmwood Ave, University of Rochester Medical Center, Rochester, NY 14642, USA; Departments of Chemical Engineering, 4510 Wegmans Hall, University of Rochester, Rochester, NY 14627, USA; Departments of Orthopaedics, 601 Elmwood Ave, University of Rochester, Rochester, NY 14642, USA; Departments of Biomedical Genetics, 601 Elmwood Ave, University of Rochester, Rochester, NY 14642, USA. Electronic address: benoit@bme.rochester.edu.

Funding

Rochester Resource-Based Center for Bone, Muscle and Orthopaedic Research (ROCSTARR) (Overall Application)P30AR069655 · NIAMS · UNIVERSITY OF ROCHESTER · PI Edward M. Schwarz · 2016 to 2026
$7.8M
Tissue Engineering Strategies to Revitalize Bone AllograftsR01AR064200 · NIAMS · UNIVERSITY OF ROCHESTER · PI Danielle S. Benoit · 2013 to 2026
$4.0M
Engineering scarless repair of flexor tendon injuriesR01AR056696 · NIAMS · UNIVERSITY OF ROCHESTER · PI AWAD, HANI A, BENOIT, DANIELLE S. · 2009 to 2019
$3.6M
Evaluation of a Novel Anti-Caries Approach to Modulate Virulence of S. mutansR01DE018023 · NIDCR · UNIVERSITY OF ROCHESTER · PI KOO, HYUN · 2008 to 2019
$3.4M
Molecular Multispectral ImagingS10RR026542 · NCRR · UNIVERSITY OF ROCHESTER · PI AWAD, HANI A · 2010 to 2010
$370k
Olympus NanoZoomer RS Whole Slide Imaging SystemS10RR027340 · NCRR · UNIVERSITY OF ROCHESTER · PI BOYCE, BRENDAN F · 2010 to 2010
$340k
NCRR NIH HHS S10 RR026542NCRR NIH HHS S10 RR027340NIAMS NIH HHS P30 AR069655NIAMS NIH HHS R01 AR056696NIAMS NIH HHS R01 AR064200NIDCR NIH HHS R01 DE018023
6 · The paper itself

Abstract

Despite great therapeutic potential and development of a repertoire of delivery approaches addressing degradation and cellular uptake limitations, small interfering RNA (siRNA) exhibits poorly controlled tissue-specific localization. To overcome this hurdle, siRNA was complexed to nanoparticles (siRNA/NP) embedded within poly(ethylene glycol)-poly(lactic acid)-dimethacrylate (PEG-PLA-DM) hydrogels with the hypothesis that hydrolytic degradation of ester bonds within the PLA crosslinks would provide tunable, sustained siRNA/NP release. Hydrogels formed from macromers with increasing PLA repeats (e.g., 0 or non-degradable to 5 PLA repeats flanking PEG cores) and mixtures of nondegradable PEG-DM (0 PLA) and degradable PEG-PLA

Indexed as

AnimalsDelayed-Action PreparationsFemaleHydrogelsMethacrylatesMice, Inbred BALB CMice, Inbred C57BLNanoparticlesPolyestersPolyethylene GlycolsRNA InterferenceRNA, Small InterferingDelayed-Action PreparationsHydrogelsMethacrylatesmonomethoxypolyethyleneglycol-polylactide block copolymerPolyesterspoly(ethylene glycol)-dimethacrylatePolyethylene Glycolspoly(lactide)RNA, Small InterferingBiomaterialsControlled deliveryDegradable hydrogelsiRNA delivery

Identifiers

PMID30077736
PMCPMC6183067

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.